INS and Hypoglycemia: The endocrine society clinical practice guideline recommends that for hospitalized adults with insulin-treated DM and noncritical illness who are at high risk for hypoglycemia, real-time CGM should be used alongside confirmatory bedside point-of-care (POC) blood glucose testing to guide insulin dosing, instead of relying solely on POC testing [127].